Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Add to Home Screen/Install App' to create a shortcut app

On The Horizon for Intramedullary Spinal Cord Tumors in Children

This page was last updated on May 9th, 2017

  • Improving pathological classification: A call has been made for a central pathological review of IMSCT specimens housed at centers where a significant number of surgeries for IMSCTs have occurred (7). Tumors are named or classified in order to predict their behavior and guide the treatment(s) delivered to them. IMSCTs have unique biologies that differ from brain tumors,  but the classification system developed for brain tumors is used to classify IMSCTs.
  • Improving tumor imaging: Diffusion tensor (DT) imaging might be a useful tool to differentiate infiltrating from non-infiltrating IMSCTs (40). While there has been no proof that surgery is beneficial for patients harboring malignant IMSCTs, current MRI is not able to unequivocally differentiate malignant from nonmalignant IMSCTs (41).  Malignant IMSCTs are much more infiltrative than nonmalignant ones, so theoretically fiber tracts should be maintained on DT imaging with nonmalignant tumors and lost with malignant tumors.

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.